These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 10824922

  • 1. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 May; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 3. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.
    Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Sep 15; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P, Orazi A, Ulbright TM, Miller GA, Haidar JH, Donohue JP, Foster RS.
    Mod Pathol; 1995 Jun 15; 8(5):492-7. PubMed ID: 7545814
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y, Haga H, Konishi I, Kobashi Y, Higuchi K, Katsuyama E, Minamiguchi S, Yamabe H.
    Cancer; 1998 Feb 01; 82(3):512-9. PubMed ID: 9452269
    [Abstract] [Full Text] [Related]

  • 7. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct 01; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 8. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW.
    Gynecol Oncol; 1994 Apr 01; 53(1):84-92. PubMed ID: 7909788
    [Abstract] [Full Text] [Related]

  • 9. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M, Steinberg SM, Mulshine JL, Linnoila RI.
    Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277
    [Abstract] [Full Text] [Related]

  • 10. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 11. Correspondence Re: Demarchi LMMF, Reis MM, Palomina SAP, Farhat C, Takagaki TY, Beyruti R, et al. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung. MOD Pathol 2000; 13:511-20.
    Vollmer RT.
    Mod Pathol; 2001 Apr 01; 14(4):366-7. PubMed ID: 11301355
    [No Abstract] [Full Text] [Related]

  • 12. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.
    Oncol Rep; 2008 Jan 01; 19(1):49-56. PubMed ID: 18097575
    [Abstract] [Full Text] [Related]

  • 13. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW.
    Cancer; 1998 Sep 01; 83(5):1002-11. PubMed ID: 9731905
    [Abstract] [Full Text] [Related]

  • 14. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P, Adelstein DJ, Myles J, Secic M.
    Laryngoscope; 2001 Nov 01; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [Abstract] [Full Text] [Related]

  • 15. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
    Fujioka S, Shomori K, Nishihara K, Yamaga K, Nosaka K, Araki K, Haruki T, Taniguchi Y, Nakamura H, Ito H.
    Lung Cancer; 2009 Aug 01; 65(2):223-9. PubMed ID: 19144445
    [Abstract] [Full Text] [Related]

  • 16. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
    Singson RP, Alsabeh R, Geller SA, Marchevsky A.
    Mod Pathol; 1999 May 01; 12(5):479-84. PubMed ID: 10349985
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 18. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
    Huh JW, Kim HR, Kim YJ.
    Ann Surg Oncol; 2009 Jun 12; 16(6):1494-500. PubMed ID: 19267156
    [Abstract] [Full Text] [Related]

  • 19. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients.
    Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY.
    Int J Oral Maxillofac Surg; 2006 Nov 12; 35(11):1005-10. PubMed ID: 17018251
    [Abstract] [Full Text] [Related]

  • 20. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M, Medrano MJ, Gutierrez A, López A, Mugüerza JM, Hernández P, Lozano O, Noguerales F, Ruíz A, Granell J.
    Anticancer Res; 2000 Nov 12; 20(5C):3929-33. PubMed ID: 11268479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.